|
Volumn 94, Issue 9, 1996, Pages 2341-2350
|
ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary
a a a a a a a a a a a a a |
Author keywords
AHA Medical Scientific Statements; angioplasty; myocardial infarction; reperfusion; thrombolysis
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANTIARRHYTHMIC AGENT;
ATROPINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOLYTIC AGENT;
GLYCERYL TRINITRATE;
HEPARIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LIDOCAINE;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NIFEDIPINE;
PETHIDINE;
ACUTE HEART INFARCTION;
BLOOD CLOT LYSIS;
BRADYCARDIA;
CORONARY ARTERY BYPASS SURGERY;
DEFIBRILLATION;
EMERGENCY HEALTH SERVICE;
GOOD CLINICAL PRACTICE;
HEART ATRIUM FIBRILLATION;
HEART BLOCK;
HEART VENTRICLE FIBRILLATION;
HEART VENTRICLE TACHYCARDIA;
HOSPITALIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PATIENT CODING;
PATIENT SELECTION;
PERICARDITIS;
PRIORITY JOURNAL;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT INDICATION;
TREATMENT PLANNING;
|
EID: 0029804941
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.94.9.2341 Document Type: Review |
Times cited : (285)
|
References (0)
|